The UNC CF Center has extensive clinical trial expertise, with an offsite facility under construction that should be available by January, 2012 and on-site hospital facilities utilizing the UNC CTSA system. We have an extensive cadre of superb clinical trial specialists and an efficient IRB system. Unique aspects of the Phase I unit pertinent to development of human pulmonary therapeutics include:

• Radionuclide Measurements of Mucociliary Clearance
• Novel Airway Surface Pharamcokinetics Techniques
• Novel Biomarkers for Pulmonary Drug Development
• Measures of the Pulmonary Microbiome

---

Inquiries

Questions? If you are interested in learning more about how the UNC CF Center can help further your research, or if you are interested in collaborating with us, please contact our CF Center Director, Dr. Richard Boucher:

7011 Thurston-Bowles Bldg.
The University of North Carolina at Chapel Hill
Campus Box #7248
Phone: (919) 966-1077
Fax: (919) 966-5178
Email: richard_boucher@med.unc.edu